Increasing demand for affordable, minimally invasive products and name-brand recognition is driving cosmetic device sales in Europe, particularly the botulinum toxin A market. (PRWeb May 21, 2013) Read the full story at http://www.prweb.com/releases/2013/5/prweb10750934.htm Business: Economy
Read More...